County vaccination data masks measles risk

Pockets of low vaccination rates in some schools help explain why measles outbreaks have been climbing in the U.S. 

Existing drug could treat invasive canine oral tumors

A new diagnostic tool distinguishes between two similar canine oral cancers, opening the door for a promising FDA-approved treatment.

A better pill to swallow: Nanofiber film delivers ultrafast pain relief

Researchers developed an ultrafast-dissolving nanofiber film that can deliver a cocktail of three drugs so quickly and effectively, 90% of the formulation is released in less than two seconds. 

Traumatic brain injury in Pakistan linked to poor long-term survival

Traumatic brain injury in Pakistan is associated with a high risk of death and disability long after the initial injury, even in mild to moderate cases.

Alum’s company creates tech for pain-free tattoos

A company founded by a Cornell doctoral alum is using microneedle technology to create a pain-free tattoo experience.

Around Cornell

Many paths, one destination: Cornell welcomes new students

The 3,681 first-year students and 603 transfers who begin moving to campus Aug. 17, hail from 49 states plus Washington, D.C., Puerto Rico and American Samoa, and 62 countries. 

Attacking cancer-enabling proteins where they live

Using a photochemically driven labeling technique, a Cornell-led research group has devised a way to capture cancer-specific protein-to-protein interactions, which could spawn targeted therapies for prostate and other forms of the disease.

Protein secreted by immune cells may help drive brain aging

Brain-resident immune cells that have reached an old-age state called “senescence” secrete a protein that causes dysfunction in other brain cells, according to Weill Cornell Medicine researchers, a finding that could shed light on memory loss.

Molecular structures provide roadmap for targeted Parkinson’s disease therapeutics

Researchers have uncovered how a key Parkinson’s protein shifts between inactive and active forms, revealing the structural changes that enable certain mutations to push the protein into an overactive state.